There are 2789 resources available
1555TiP - A phase II single-arm study of pembrolizumab plus lenvatinib in previously treated classic Kaposi sarcoma (CKS): The PULSAR trial
Presenter: Alice Indini
Session: ePoster Display
1568P - Clinical and laboratory outcomes of solid cancer patients reinfected with SARS-CoV-2
Presenter: Ozan Yazıcı
Session: ePoster Display
1569P - A multicenter analysis of the outcome of cancer patients with neutropenia and COVID-19 infection optionally treated with granulocyte colony-stimulating factor (G-CSF): A comparative analysis
Presenter: Maria Sereno Moyano
Session: ePoster Display
1570P - Outcome and prognostic factors of COVID-19 infection in cancer patients: Final results of SAKK 80/20
Presenter: Markus Joerger
Session: ePoster Display
1571P - COVID-19 positivity rates in patients with an active cancer diagnosis in the University of California Cancer Consortium
Presenter: Julian Hong
Session: ePoster Display
1572P - The impact of COVID-19 pandemic on Spanish genitourinary (GU) cancer patients: SOGUG-COVID-19 study
Presenter: Miguel Angel Climent Duran
Session: ePoster Display
1573P - First wave mortality data versus full pandemic period from the COVID-CANCER HUIL study
Presenter: Gloria Serrano-Montero
Session: ePoster Display
1574P - Mortality of 1,636 COVID-19 cancer patients (pts) and associated prognostic factors
Presenter: Paolo Ascierto
Session: ePoster Display
1575P - Systemic anti-cancer therapy and metastatic cancer are independent mortality risk factors during two UK waves of the COVID-19 pandemic at University College London Hospital
Presenter: Alasdair Sinclair
Session: ePoster Display